What is NDC 55154-7353?

55154-7353 is the product NDC for Sodium Polystyrene Sulfonate, Sodium polystyrene sulfonate 15 g/60mL suspension, listed with the FDA by Cardinal Health 107, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Cardinal Health 107, LLC, NDC labeler code 55154. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sodium Polystyrene Sulfonate?

14 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sodium Polystyrene Sulfonate NDC 55154-7353

NDC codes

FDA NDC Directory

Product NDC (as listed)55154-7353Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55154-7353Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55154-7353-2	5515473530255154735302	2 BOTTLE, UNIT-DOSE in 1 BAG (55154-7353-2) / 60 mL in 1 BOTTLE, UNIT-DOSEMarketed from Jan 1, 1983

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Polystyrene Sulfonate
Generic name (nonproprietary): sodium polystyrene sulfonate
Active ingredients: Sodium polystyrene sulfonate — 15 g/60mL
Dosage form: Suspension
Route: Oral, Rectal
Labeler: Cardinal Health 107, LLCNDC labeler code 55154
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 087859
Marketing start: Jan 1, 1983
Listing expires: Dec 31, 2027
Identifiers: Product ID 55154-7353_5e6183a1-2936-4910-b177-77c9d2b44bfeSPL ID 5e6183a1-2936-4910-b177-77c9d2b44bfe

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N455154735302 followed by a unit qualifier and the quantity

Package 55154-7353-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 55154-7353

What is NDC 55154-7353?: 55154-7353 is the product NDC for Sodium Polystyrene Sulfonate, Sodium polystyrene sulfonate 15 g/60mL suspension, listed with the FDA by Cardinal Health 107, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sodium Polystyrene Sulfonate.
What is the active ingredient?: Sodium polystyrene sulfonate.
Who is the labeler?: Cardinal Health 107, LLC, NDC labeler code 55154. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sodium Polystyrene Sulfonate?: 14 other product NDCs are listed under this name. See all Sodium Polystyrene Sulfonate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sodium Polystyrene Sulfonate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 15 g/60mL	SuspensionOral, Rectal	Burel Pharmaceuticals, LLC	35573-108	35573-0108-1435573-0108-57
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	SUNRISE PHARMACEUTICAL, INC.	11534-166	11534-0166-1511534-0166-1611534-0166-44
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	Bryant Ranch Prepack	63629-2390	63629-2390-01
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	Bryant Ranch Prepack	63629-8849	63629-8849-01
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	Bryant Ranch Prepack	63629-8850	63629-8850-01
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	Bryant Ranch Prepack	71335-2855	71335-2855-01
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	Bryant Ranch Prepack	72162-1230	72162-1230-0272162-1230-07
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral	PuraCap Laboratories, LLC	24658-760	24658-0760-16
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	Chartwell RX, LLC	62135-340	62135-0340-1162135-0340-5362135-0340-62
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral	ATLANTIC BIOLOGICALS CORP.	17856-0024	17856-0024-0117856-0024-02

All 15 Sodium Polystyrene Sulfonate NDCs

Other NDCs under ANDA 087859

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 087859
Product	Strength	Form · route	Labeler	Product NDC
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 15 g/60mL	SuspensionOral, Rectal	CMP Pharma, Inc.	46287-006